OpGen Inc
Diagnostics & Research
Healthcare
OPGN
47.66 M shares
NASDAQ US
traded
05 Apr 2023
listed
yes
open
1.31
52 week high
3.58
high
1.36
52 week low
1.32
low
1.29
growth
-49.81 %
previous Close
1.32
P/E ratio
-0
market cap
3.51 M
div yield
0
usd
Sep 2022
qoq
revenue
449 K
-53.61 %
net incoming
-14.10 M
-141.49 %
eps
-6.00 %
-130.77 %
eps surprise
-150.00 %
net profit margin
-3143.21 %
-2539.00 %
operating incoming
-13.51 M
-156.31 %
net change in cash
-6.33 M
55.07 %
cash on hand
10.28 M
-38.05 %
cost of revenue
1.90 M
187.51 %
top top